ProfessionalNo New Dates

What’s Happening with MDMA-Assisted Therapy for PTSD?

This course examines MDMA-assisted therapy for PTSD, including the substance’s history, current clinical research, and safety considerations in controlled therapeutic settings. It also outlines key contraindications and major studies shaping the evidence base.

Provider

Beckley Academy

English

Schedule

60 years

Enrollment

Price on request

Course Overview

This course provides an overview of MDMA as a potential treatment for post-traumatic stress disorder (PTSD). It traces MDMA’s history from early psychiatric use to recreational adoption and renewed clinical interest. The content focuses on the current research landscape, including work led by MAPS and findings on safety and efficacy when MDMA is used under professional guidance in controlled settings. It also reviews important safety considerations and contraindications discussed in the source material. The course is relevant for clinicians, therapists, and other mental health professionals interested in emerging PTSD treatments and the evidence supporting MDMA-assisted therapy.

Who is this for?

Clinicians, therapists, and other mental health professionals interested in MDMA-assisted therapy and PTSD treatment research.

About the Provider

Psychedelic-assisted therapy training arm co-founded by Beckley Waves and guided by Amanda Feilding, drawing on the Beckley Foundation's pioneering research. Offers cohort-based and self-managed courses for licensed mental health professionals in ketamine-, psilocybin-, and MDMA-assisted therapy, and published the first open-source Psychedelic-Assisted Therapy Learning Framework.

Related Courses

View all courses